Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

May 6, 2021

284_dirs_2021-05-06_fdc8e86a-fab9-4ca3-910c-293823ae71cf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-05-04

Reporting Person: MIZELL STEVEN (EVP, Chief HR Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-04 Stock Option (Right to Buy) $75.99 A 64286 Acquired 2031-05-03 Common Stock (64286) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23181.145 Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.